Indication

Heavy menstrual bleeding associated with uterine leiomyoma

Heavy menstrual bleeding associated with uterine leiomyoma is a gynecologic condition characterized by excessive, prolonged, or disruptive uterine blood loss during menstruation secondary to benign monoclonal smooth muscle tumors (fibroids) within the myometrium. Read more about Heavy menstrual bleeding associated with uterine leiomyoma

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Heavy menstrual bleeding associated with uterine leiomyoma therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Heavy menstrual bleeding associated with uterine leiomyoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Heavy menstrual bleeding associated with uterine leiomyoma.

Heavy menstrual bleeding associated with uterine leiomyoma is a gynecologic condition characterized by excessive, prolonged, or disruptive uterine blood loss during menstruation secondary to benign monoclonal smooth muscle tumors (fibroids) within the myometrium.

Primarily affecting premenopausal women, it stems from structural and vascular alterations, including expansion of the endometrial surface area, distortion of the uterine cavity, abnormal myometrial contractility, and dysregulated endometrial angiogenesis and venous drainage.

Clinically, affected patients experience abnormally heavy menstrual flow, often defined as blood loss exceeding 80 mL per cycle or requiring frequent sanitary product changes, which frequently leads to chronic iron-deficiency anemia, pelvic pressure, and substantial fatigue.

Personalize your experience

Follow Heavy menstrual bleeding associated with uterine leiomyoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it